The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer.

 
Web www.patentalert.com

< Bardet-Biedl susceptibility gene and uses thereof

< Oil or fat composition

> VGF fusion polypeptides

> Melanocortin 1 receptor selective compounds

~ 00243